View by Specialty

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

Pediatric Dermatology News

SPONSORED CONTENT
January 04, 2025
2 min read
Save
Infants with atopic dermatitis, high-risk factors more likely to experience atopic march

Infants with atopic dermatitis, high-risk factors more likely to experience atopic march

Severe disease, male sex, family history and prenatal factors were significantly associated with an increased risk for atopic march progression in infants with atopic dermatitis, according to a study.

SPONSORED CONTENT
January 03, 2025
2 min read
Save

Long-term follow-up in anogenital lichen sclerosus needed to prevent morbidities

Long-term follow-up in anogenital lichen sclerosus needed to prevent morbidities

Anogenital lichen sclerosus can lead to permanent anatomical changes and sexual discomfort in women, highlighting a need for long-term follow-up and high treatment adherence, the latter of which is lacking, according to a study.

SPONSORED CONTENT
January 02, 2025
2 min read
Save

Pediatric dermatologists positioned to educate children, parents on female anatomy

Pediatric dermatologists positioned to educate children, parents on female anatomy

Pediatric dermatologists are well positioned to educate children and adults on the correct terms for female anatomy to ensure proper diagnoses and treatments, according to a study.

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

SPONSORED CONTENT
December 27, 2024
2 min read
Save

Healio compiles top pediatric dermatology articles of 2024

Healio compiles top pediatric dermatology articles of 2024

As 2024 comes to a close, Healio has assembled this year’s most-read pediatric dermatology articles.

SPONSORED CONTENT
December 20, 2024
2 min read
Save

Arcutis submits sNDA for Zoryve cream 0.05% to treat AD in children aged 2 to 5 years

Arcutis submits sNDA for Zoryve cream 0.05% to treat AD in children aged 2 to 5 years

Arcutis Biotherapeutics has submitted a supplemental new drug application to the FDA for Zoryve cream 0.05% for the treatment of pediatric mild to moderate atopic dermatitis, according to a press release.

SPONSORED CONTENT
December 20, 2024
4 min read
Save

Healthy boy with sore on left lower eyelid

Healthy boy with sore on left lower eyelid

A healthy 5-year-old boy, whose only problem had been mild-to-moderate seborrheic dermatitis, is taken to his provider with the complaint of a sore on his left lower eyelid.

SPONSORED CONTENT
December 06, 2024
5 min watch
Save

Beneath the Surface: Investigating dupilumab’s use in pediatric alopecia areata treatment

Beneath the Surface: Investigating dupilumab’s use in pediatric alopecia areata treatment

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio cDermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

SPONSORED CONTENT
December 04, 2024
2 min read
Save

Infantile hemangiomas thicker with steeper borders in preterm infants

Infantile hemangiomas thicker with steeper borders in preterm infants

Preterm infants more often presented with infantile hemangiomas that were thicker with steeper borders compared with term infants, signaling a need for improved treatment, according to a study.

SPONSORED CONTENT
December 03, 2024
1 min read
Save

Johnson & Johnson submits sBLAs for Tremfya for two pediatric indications

Johnson & Johnson submits sBLAs for Tremfya for two pediatric indications

Johnson & Johnson has submitted two supplemental biologics license applications to the FDA for Tremfya for the treatment of plaque psoriasis and juvenile psoriatic arthritis in children, the company announced in a press release.

SPONSORED CONTENT
December 01, 2024
2 min read
Save

Exclusive interview on 2025 physician fee schedule cuts leads November dermatology news

Exclusive interview on 2025 physician fee schedule cuts leads November dermatology news

An in-depth interview about the effects of the CMS’s 2025 physician fee schedule on patient access topped Healio Dermatology’s most-read articles of November, with FDA news also garnering attention.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails